DAM
BIO icon

Delta Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Delta Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8
Closed -$2K – 687
2017
Q3 		$2K Buy
+8
New +$1.8K ﹤0.01% 556
2017
Q2 		– Sell
-32
Closed -$6K – 595
2017
Q1 		$6K Hold
32
– – ﹤0.01% 483
2016
Q4 		$6K Hold
32
– – ﹤0.01% 473
2016
Q3 		$5K Hold
32
– – ﹤0.01% 488
2016
Q2 		$5K Hold
32
– – ﹤0.01% 480
2016
Q1 		$4K Hold
32
– – ﹤0.01% 490
2015
Q4 		$4K Hold
32
– – ﹤0.01% 500
2015
Q3 		$4K Buy
+32
New +$4.61K ﹤0.01% 492

Other funds holding BIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $162M AUM 3.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return